首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Peroxynitrite enhances astrocytic volume-sensitive excitatory amino acid release via a src tyrosine kinase-dependent mechanism.
【24h】

Peroxynitrite enhances astrocytic volume-sensitive excitatory amino acid release via a src tyrosine kinase-dependent mechanism.

机译:过亚硝酸盐通过src酪氨酸激酶依赖性机制增强星形细胞的体积敏感性兴奋性氨基酸释放。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Volume-regulated anion channels (VRACs) are critically important for cell volume homeostasis, and under pathological conditions contribute to neuronal damage via excitatory amino (EAA) release. The precise mechanisms by which brain VRACs are activated and/or modulated remain elusive. In the present work we explored the possible involvement of nitric oxide (NO) and NO-related reactive species in the regulation of VRAC activity and EAA release, using primary astrocyte cultures. The NO donors sodium nitroprusside and spermine NONOate did not affect volume-activated d-[3H]aspartate release. In contrast, the peroxynitrite (ONOO-) donor 3-morpholinosydnomine hydrochloride (SIN-1) increased volume-dependent EAA release by approx. 80-110% under identical conditions. Inhibition of ONOO- formation with superoxide dismutase completely abolished the effects of SIN-1. Both the volume- and SIN-1-induced EAA release were sensitive to the VRAC blockers NPPB and ATP. Further pharmacological analysis ruled out the involvement of cGMP-dependent reactions and modification of sulfhydryl groups in the SIN-1-inducedmodulation of EAA release. The src family tyrosine kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d]pyrimidine (PP2), but not its inactive analog PP3, abolished the effects of SIN-1. A broader spectrum tyrosine kinase inhibitor tyrphostin A51, also completely eliminated the SIN-1-induced EAA release. Our data suggest that ONOO- up-regulates VRAC activity via a src tyrosine kinase-dependent mechanism. This modulation may contribute to EAA-mediated neuronal damage in ischemia and other pathological conditions favoring cell swelling and ONOO- production.
机译:体积调节阴离子通道(VRAC)对于细胞体积稳态至关重要,在病理条件下会通过兴奋性氨基(EAA)释放而导致神经元损伤。激活和/或调节大脑VRAC的确切机制仍然难以捉摸。在当前的工作中,我们探索了使用原代星形胶质细胞培养物一氧化氮(NO)和与NO相关的反应性物种可能参与的VRAC活性和EAA释放的调节。 NO供体硝普钠和精胺NONOate不会影响体积活化的d- [3H]天冬氨酸的释放。相比之下,过氧亚硝酸盐(ONOO-)供体3-吗啉代亚胺盐酸盐(SIN-1)使体积依赖性EAA释放量增加了约20%。在相同条件下为80-110%。用超氧化物歧化酶抑制ONOO-的形成完全消除了SIN-1的作用。体积诱导和SIN-1诱导的EAA释放均对VRAC阻滞剂NPPB和ATP敏感。进一步的药理学分析排除了cGMP依赖性反应和巯基修饰参与SIN-1诱导的EAA释放调节。 src家族酪氨酸激酶抑制剂4-氨基-5-(4-氯苯基)-7-(叔丁基)吡唑并[3,4-d]嘧啶(PP2),但不是其非活性类似物PP3,则消除了SIN的作用-1。广谱的酪氨酸激酶抑制剂酪氨酸抑制蛋白A51也完全消除了SIN-1诱导的EAA释放。我们的数据表明ONOO-通过src酪氨酸激酶依赖性机制上调VRAC活性。这种调节可能在缺血和其他有利于细胞肿胀和ONOO产生的病理状态下促进EAA介导的神经元损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号